Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals

NCT06973174 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2010-01-01
Last updated
2026-01-28

Condition(s) studied

SepsisInfections

Investigational drug(s) / intervention(s)

Premature neonates with invasive infection caused by Bacillus cereus

Premature neonates with invasive infection caused by Bacillus cereus: The whole genome sequencing of the bacterial strains was performed by using both Illumina and Nanopore technologies, allowing us to obatin high quality and complete circular genomes.

Study summary

Background. Bacillus cereus group (Bc) comprises twenty-six closely related species of spore-forming environmental bacteria. Recently, increased sepsis and septic shock caused by Bc were reported in preterm neonates (PN), and the mortality rate can reach up to 30%. Using Whole Genome Sequencing (WGS) increasingly used to characterize Bc strains, The team aimed to determine an accurate identification to the species level of the strains involved in Bc invasive infections in preterm neonates in France and study their virulome profile.Methods. The team performed WGS for 40 neonate clinical strains responsible for invasive infections in PN. A screening of virulence genes was performed to characterize strains associated with poor prognosis. Clinical data were collected and all clinical and genomic findings were analyzed for risk factors for death.

"

Eligibility

Sex
ALL
Min age
—
Max age
143 Days
Healthy volunteers
No
Inclusion Criteria: * Premature newborn (i.e born before 37 last menstrual periods) with invasive infection caused by B. cereus (strains isolated from blood culture and cerebrsopinal fluid) Exclusion Criteria: * None

Primary outcome measure(s)

  • Mortality — 28 days after birth
    The mortality at D28 after birth was collected in patients record.

Trial sites (13)

FacilityCityRegionStatus
CHU NICE Nice Alpes Maritimes Recruiting
CHU lille Lille France Recruiting
AP-HM Marseille Marseille France Recruiting
CHU Nantes Nantes France Recruiting
CHU Nîmes Nîmes France Recruiting
AP-HP Hôpital Robert Debré Paris France Recruiting
Hôpital Antoine Béclère, AP-HP Paris France Recruiting
Hôpital Cochin Paris France Recruiting
CHU de Poitiers Poitiers France Recruiting
CHU Rennes Rennes France Recruiting
CHRU de Strasbourg Strasbourg France Recruiting
CHU Toulouse Toulouse France Recruiting
CHU de Tours Tours France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06973174 on ClinicalTrials.gov ↗ ← All trials in France